Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon

 
Rachel Tan, Biljana Cvetkovski, Vicky Kritikos, David Price, Kwok Yan, Pete Smith and Sinthia Bosnic-Anticevich
Asthma Research and Practice 2017 3:8

https://doi.org/10.1186/s40733-017-0036-z

Abstract

Background

Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from health care intervention. The primary point of health care contact for these self-managing allergic rhinitis patients is the community pharmacy. With the majority of allergic rhinitis treatments being available for purchase over the counter, without health care professional contact, we know little about how the patients self-manage. This study aims to identify the burden of allergic rhinitis in the community pharmacy and to identify key opportunity for intervention.

Methods

Pharmacy customers, who purchased nasal treatment in a community pharmacy, were approached with a research-administered questionnaire that collected data on medical history, symptoms and products purchased for the treatment of nasal symptoms.

Results

Of the 296 participants, 69.9% self-managed with over-the-counter medications; with 68% experiencing allergic rhinitis symptoms and only 44.3% of this subgroup had a doctor’s diagnosis. Nasal congestion (73.6%) was most commonly experienced and oral antihistamines were most commonly purchased (44.3%), indicating a pattern of suboptimal management. A third of participants (36.5%) experienced moderate-severe symptoms, persistently, which impacted on their daily living. Medication selection was mainly based on pharmacy customers’ perceptions of medication effectiveness (47.6%).

Conclusion

A majority of participants that self-selected over-the-counter medications have symptoms consistent with allergic rhinitis, with almost half not having received a diagnosis. Medication purchasing patterns suggest that sub-optimal therapeutic decisions made by participants, even when they are experiencing significant symptoms. This study uncovers the hidden burden of allergic rhinitis in the community pharmacy and a missed opportunity to intervene and refer if necessary. Patients need to be guided through appropriate treatment as this study showed that many should be referred to a medical practitioner.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @BioMedCentral: World Allergy Organization Journal receives 70,000 accesses worldwide per month @worldallergy #openaccess https://t.co/I
4hreplyretweetfavorite
Interasma RT @BioMedCentral: Publish #openaccess in World Allergy Organization Journal, official journal of the @worldallergy https://t.co/d7VTeQ1AkF
4hreplyretweetfavorite
Interasma RT @Aller_MD: The latest Allergy, Asthma & Immunology! https://t.co/G4dPzJldLA #londonmarathon
4hreplyretweetfavorite
Interasma RT @Aller_MD: The latest Allergists on Social Media! https://t.co/3TIxr4Dteg Thanks to @ThoraxBMJ @ACAAI @sergiobarbaecua #londonmarathon
4hreplyretweetfavorite
Interasma RT @worldallergy: April 22-28 is World Allergy Week 2018. Help increase awareness of Atopic Dermatitis/Eczema: An Itch that Rashes. There a…
4hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma